BioVaxys Announces Application for Management Cease Trade Order
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in ...
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
The Committed Equity Facility agreement provides Aptose the right, in its sole option and discretion without obligation, to sell and issue up to $25 million of its common shares (the “Common Shares”) ...
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in ...
News Medical9h
Study breaks down Alzheimer's treatment effects in clear terms
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...
Implantica announces positive feedback received from U.S. FDA of the RefluxStop PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop ...
News Medical23h
New research advances understanding of Parkinson's disease stages
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...